Posted in


UF researchers developing new cancer immunotherapy drug

UF pharmacy researchers have found a potential new way of targeting a population of immune-suppressive T cells that could possibly benefit a large population of cancer patients, including those who will not respond to other immunotherapies.

Dr. Guillaume de Lartigue receives NIDDK grant

Guillaume de Lartigue, Ph.D.,  an assistant professor of pharmacodynamics, is a multiple principal investigator of a National Institute of Diabetes and Digestive and Kidney Diseases R01 grant, which began July 1, 2020. Dr. Guillaume de Lartigue The grant titled “Consequence and mechanism of diet-driven vagal remodeling on gut-brain feeding behavior” will…

Dr. Daohong Zhou receives National Cancer Institute R01 grant

Daohong Zhou, M.D., a professor of pharmacodynamics, has received multiple recent grants, including a multiple principal investigator R01 from the National Cancer Institute, alongside his longtime collaborator Guangrong Zheng, Ph.D., an associate professor of medicinal chemistry Dr. Daohong Zhou The grant titled “Inhibition of Bcl-xL by Targeted Degradation” will carry…

Meera Rath successfully defends her dissertation

Congratulations to Meera Rath for successfully defending her dissertation, “Exploring the role of microglia in chronic voluntary binge ethanol consumption mouse model,” on Oct. 21. Committee members included Bin Liu, Ph.D.; Joanna Peris, Ph.D.; Jay McLaughlin, Ph.D.; Stanley Stevens, Jr., Ph.D.; Eric Krause, Ph.D.; and Christopher Vulpe, M.D., Ph.D. Rath…